Varshochi R et al. |
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. |
2005 |
J. Biol. Chem. |
pmid:15557281
|
Alao JP et al. |
Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. |
2004 |
Clin. Cancer Res. |
pmid:15585645
|
Sato N et al. |
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. |
2005 |
Oncogene |
pmid:15592528
|
Karasawa Y and Okisaka S |
Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells. |
2004 Nov-Dec |
Jpn. J. Ophthalmol. |
pmid:15592778
|
Davidson SM et al. |
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. |
2005 |
Chembiochem |
pmid:15593114
|
Goeman F et al. |
Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. |
2005 |
Mol. Cell. Biol. |
pmid:15601862
|
Bayart E et al. |
A major role for mitotic CDC2 kinase inactivation in the establishment of the mitotic DNA damage checkpoint. |
2004 |
Cancer Res. |
pmid:15604258
|
Zhao Y et al. |
Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15607742
|
Fujisawa K et al. |
Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas. |
2005 |
Lab. Invest. |
pmid:15608662
|
Bottardi S et al. |
Onset and inheritance of abnormal epigenetic regulation in hematopoietic cells. |
2005 |
Hum. Mol. Genet. |
pmid:15615768
|
Ezzat S et al. |
The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility. |
2005 |
Mol. Endocrinol. |
pmid:15618287
|
Maxhimer JB et al. |
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). |
2005 |
J. Thorac. Cardiovasc. Surg. |
pmid:15632825
|
Kondo T et al. |
Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. |
2005 |
Oncogene |
pmid:15637589
|
Senawong T et al. |
BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. |
2005 |
Arch. Biochem. Biophys. |
pmid:15639232
|
Farrajota K et al. |
Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. |
2005 |
Arthritis Rheum. |
pmid:15641079
|
Huang W et al. |
Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. |
2005 |
J. Biol. Chem. |
pmid:15647279
|
Choi JH et al. |
Trichostatin A attenuates airway inflammation in mouse asthma model. |
2005 |
Clin. Exp. Allergy |
pmid:15649272
|
Kang J et al. |
Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells. |
2005 |
Toxicol In Vitro |
pmid:15649630
|
Shindo N et al. |
The ESC-E(Z) complex participates in the hedgehog signaling pathway. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15652519
|
Kemp MG et al. |
The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells. |
2005 |
Nucleic Acids Res. |
pmid:15653633
|
Huang H et al. |
MEIS C termini harbor transcriptional activation domains that respond to cell signaling. |
2005 |
J. Biol. Chem. |
pmid:15654074
|
Danam RP et al. |
Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. |
2005 |
Mol. Cancer Ther. |
pmid:15657354
|
Li Y et al. |
Histone deacetylation is required for progression through mitosis in tobacco cells. |
2005 |
Plant J. |
pmid:15659094
|
Marsili G et al. |
Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription. |
2004 |
Ann. N. Y. Acad. Sci. |
pmid:15659847
|
Schmittwolf C et al. |
In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. |
2005 |
EMBO J. |
pmid:15660132
|
Endo M et al. |
Novel gender-related regulation of CYP2C12 gene expression in rats. |
2005 |
Mol. Endocrinol. |
pmid:15661834
|
Keen JC et al. |
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells. |
2004 |
Cancer Biol. Ther. |
pmid:15662126
|
Sengupta S et al. |
Tumor suppressor p53 represses transcription of RECQ4 helicase. |
2005 |
Oncogene |
pmid:15674334
|
Busson M et al. |
Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. |
2005 |
Oncogene |
pmid:15674337
|
Ding W |
[A histone deacetylase inhibitor and tumor suppressing gene p53 induction synergistically induce apoptosis of cancer cells]. |
2004 |
Hokkaido Igaku Zasshi |
pmid:15675303
|
Wen J et al. |
Tal1/SCL binding to pericentromeric DNA represses transcription. |
2005 |
J. Biol. Chem. |
pmid:15677454
|
Yamashita Y et al. |
cDNA microarray analysis in hepatocyte differentiation in Huh 7 cells. |
2004 |
Cell Transplant |
pmid:15690981
|
Zhao Y et al. |
Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. |
2005 |
J. Exp. Biol. |
pmid:15695762
|
Illi B et al. |
Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. |
2005 |
Circ. Res. |
pmid:15705964
|
Jalonen U et al. |
Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. |
2005 |
Biochem. Pharmacol. |
pmid:15710351
|
Hooven LA et al. |
Effects of suberoylanilide hydroxamic acid and trichostatin A on induction of cytochrome P450 enzymes and benzo[a]pyrene DNA adduct formation in human cells. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:15713371
|
Chen B et al. |
Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:15713393
|
Duan H et al. |
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. |
2005 |
Mol. Cell. Biol. |
pmid:15713621
|
Tong X et al. |
Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. |
2005 |
J. Biol. Chem. |
pmid:15713675
|
Gan Y et al. |
Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. |
2005 |
J. Biol. Chem. |
pmid:15722551
|
Endo T et al. |
Changes in histone modifications during in vitro maturation of porcine oocytes. |
2005 |
Mol. Reprod. Dev. |
pmid:15736133
|
Emionite L et al. |
Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736447
|
Fan S et al. |
Valproic acid enhances gene expression from viral gene transfer vectors. |
2005 |
J. Virol. Methods |
pmid:15737413
|
Sonnemann J et al. |
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. |
2005 |
Invest New Drugs |
pmid:15744585
|
ChuÄkin IA et al. |
[Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells]. |
2004 |
Tsitologiia |
pmid:15747838
|
Koh SH et al. |
Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15752760
|
Mori T et al. |
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. |
2005 |
Cancer Res. |
pmid:15753377
|
Dowling M et al. |
Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. |
2005 |
Cancer Biol. Ther. |
pmid:15753652
|
Hu J and Colburn NH |
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. |
2005 |
Mol. Cancer Res. |
pmid:15755876
|
Wagner S and Roemer K |
Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf. |
2005 |
Biochem. Pharmacol. |
pmid:15763542
|
Kawamura T et al. |
Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. |
2005 |
J. Biol. Chem. |
pmid:15764815
|
Dote H et al. |
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. |
2005 |
Br. J. Cancer |
pmid:15770214
|
Laberge RM and Boissonneault G |
On the nature and origin of DNA strand breaks in elongating spermatids. |
2005 |
Biol. Reprod. |
pmid:15772260
|
McKenzie GJ et al. |
Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. |
2005 |
J. Neurochem. |
pmid:15773917
|
Subramanian C et al. |
Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15778293
|
Lu ZP et al. |
Histone deacetylase inhibitor Trichostatin A reduces anti-DNA autoantibody production and represses IgH gene transcription. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15781251
|
Nishigaki M et al. |
Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. |
2005 |
Cancer Res. |
pmid:15781621
|
Bai J et al. |
Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. |
2005 |
Cancer Res. |
pmid:15781649
|
Rahmani M et al. |
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. |
2005 |
Cancer Res. |
pmid:15781658
|
Frescas D et al. |
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. |
2005 |
J. Biol. Chem. |
pmid:15788402
|
Li X et al. |
Regulation of histone acetylation and apoptosis by trichostatin in HL-60 cells. |
2004 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:15791844
|
Kang J et al. |
Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. |
2005 |
Biochem. Pharmacol. |
pmid:15794941
|
Narayanan R et al. |
Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. |
2005 |
Mol. Cell. Biol. |
pmid:15798179
|
Xiong Y et al. |
Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. |
2005 |
Cancer Res. |
pmid:15805266
|
Kumakura S et al. |
Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. |
2005 |
Cancer Res. |
pmid:15805278
|
Zhao W et al. |
The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. |
2005 |
J. Biochem. |
pmid:15809347
|
Komata T et al. |
Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. |
2005 |
Int. J. Oncol. |
pmid:15809727
|
Blais M et al. |
Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter. |
2005 |
DNA Cell Biol. |
pmid:15812237
|
Young DA et al. |
Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. |
2005 |
FEBS J. |
pmid:15819885
|
Xu S et al. |
Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. |
2005 |
J. Hum. Genet. |
pmid:15824892
|
Strait KA et al. |
Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad. |
2005 |
Mol. Cancer Ther. |
pmid:15827334
|
Magner WJ and Tomasi TB |
Apoptotic and necrotic cells induced by different agents vary in their expression of MHC and costimulatory genes. |
2005 |
Mol. Immunol. |
pmid:15829293
|
Gonçalves J et al. |
Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells. |
2005 |
Clin. Chem. Lab. Med. |
pmid:15843208
|
Robbins AR et al. |
Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin. |
2005 |
Cell Cycle |
pmid:15846093
|
Taghiyev AF et al. |
Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. |
2005 |
Cancer Biol. Ther. |
pmid:15846101
|
Barki-Celli L et al. |
Differences in nuclear positioning of 1q12 pericentric heterochromatin in normal and tumor B lymphocytes with 1q rearrangements. |
2005 |
Genes Chromosomes Cancer |
pmid:15846776
|
Song Y et al. |
[The mechanisms of p21WAF1/Cip-1 expression in MOLT-4 cell line induced by TSA]. |
2005 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:15854272
|
Xu ZM et al. |
[Analysis of the methylation in the promoter of LRP15 gene and its expression]. |
2005 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:15854274
|
Mai A et al. |
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. |
2005 |
J. Med. Chem. |
pmid:15857140
|
Galfi P et al. |
Divergent effects of resveratrol, a polyphenolic phytostilbene, on free radical levels and type of cell death induced by the histone deacetylase inhibitors butyrate and trichostatin A. |
2005 |
J. Steroid Biochem. Mol. Biol. |
pmid:15862948
|
Choi KH et al. |
Activation of CMV promoter-controlled glycosyltransferase and beta -galactosidase glycogenes by butyrate, tricostatin A, and 5-aza-2'-deoxycytidine. |
2005 |
Glycoconj. J. |
pmid:15864436
|
Touma SE et al. |
Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. |
2005 |
Clin. Cancer Res. |
pmid:15867260
|
Fish JE et al. |
The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. |
2005 |
J. Biol. Chem. |
pmid:15870070
|
Dyson MH et al. |
MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2. |
2005 |
J. Cell. Sci. |
pmid:15870105
|
Reid G et al. |
Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. |
2005 |
Oncogene |
pmid:15870696
|
Kim MS et al. |
Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). |
2005 |
Exp. Cell Res. |
pmid:15878336
|
Rosenqvist N et al. |
Inhibition of chromatin condensation prevents transgene silencing in a neural progenitor cell line transplanted to the rat brain. |
2005 |
Cell Transplant |
pmid:15881422
|
Camelo S et al. |
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. |
2005 |
J. Neuroimmunol. |
pmid:15885809
|
Peltonen K et al. |
Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis. |
2005 |
Pigment Cell Res. |
pmid:15892716
|
Schwahn DJ et al. |
Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. |
2005 |
Pigment Cell Res. |
pmid:15892717
|
Ho WC et al. |
Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. |
2005 |
Cancer Res. |
pmid:15899819
|
Tran T et al. |
Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. |
2005 |
Cancer Res. |
pmid:15899836
|
Gurvich N et al. |
Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. |
2005 |
FASEB J. |
pmid:15901671
|
Ranganathan P and Rangnekar VM |
Exploiting the TSA connections to overcome apoptosis-resistance. |
2005 |
Cancer Biol. Ther. |
pmid:15908800
|
Rincón-Arano H et al. |
YY1 and GATA-1 interaction modulate the chicken 3'-side alpha-globin enhancer activity. |
2005 |
J. Mol. Biol. |
pmid:15913647
|
Law RD and Suttle JC |
Chromatin remodeling in plant cell culture: patterns of DNA methylation and histone H3 and H4 acetylation vary during growth of asynchronous potato cell suspensions. |
2005 |
Plant Physiol. Biochem. |
pmid:15922608
|
Seo H et al. |
Rapid generation of specific antibodies by enhanced homologous recombination. |
2005 |
Nat. Biotechnol. |
pmid:15924134
|
Gray SG et al. |
Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. |
2005 |
J. Biol. Chem. |
pmid:15927959
|
Gunin AG et al. |
Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. |
2005 |
J. Endocrinol. |
pmid:15930180
|
Wittich S et al. |
Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines. |
2005 |
Anticancer Drugs |
pmid:15930892
|